Carnitor is a drug owned by Leadiant Biosciences Inc. It is protected by 3 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 18, 2021. Details of Carnitor's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6696493 | Treating chronic uremic patients undergoing periodic dialysis |
Jan, 2021
(3 years ago) |
Expired
|
| US6335369 | Treating chronic uremic patients undergoing periodical dialysis |
Jan, 2021
(3 years ago) |
Expired
|
| US6429230 | Treating chronic uremic patients undergoing periodical dialysis |
Jan, 2021
(3 years ago) |
Expired
|
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Carnitor's patents.
Latest Legal Activities on Carnitor's Patents
Given below is the list of recent legal activities going on the following patents of Carnitor.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| File Marked Found | 19 Jan, 2016 | US6335369 |
| File Marked Found | 19 Jan, 2016 | US6696493 |
| File Marked Found | 19 Jan, 2016 | US6429230 |
| File Marked Found | 14 Jan, 2016 | US6335369 |
| File Marked Found | 14 Jan, 2016 | US6696493 |
| File Marked Found | 14 Jan, 2016 | US6429230 |
| Correspondence Address Change Critical | 05 Jun, 2006 | US6429230 |
| Recordation of Patent Grant Mailed Critical | 24 Feb, 2004 | US6696493 |
| Patent Issue Date Used in PTA Calculation Critical | 24 Feb, 2004 | US6696493 |
| Issue Notification Mailed Critical | 05 Feb, 2004 | US6696493 |
US patents provide insights into the exclusivity only within the United States, but Carnitor is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Carnitor's family patents as well as insights into ongoing legal events on those patents.
Carnitor's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Carnitor's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 18, 2021 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Carnitor Generic API suppliers:
Levocarnitine is the generic name for the brand Carnitor. 6 different companies have already filed for the generic of Carnitor, with Novitium Pharma having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Carnitor's generic
About Carnitor
Carnitor is a drug owned by Leadiant Biosciences Inc. It is used for treating and preventing carnitine deficiency in end stage renal disease patients undergoing dialysis. Carnitor uses Levocarnitine as an active ingredient. Carnitor was launched by Leadiant Biosci Inc in 1992.
Approval Date:
Carnitor was approved by FDA for market use on 16 December, 1992.
Active Ingredient:
Carnitor uses Levocarnitine as the active ingredient. Check out other Drugs and Companies using Levocarnitine ingredient
Treatment:
Carnitor is used for treating and preventing carnitine deficiency in end stage renal disease patients undergoing dialysis.
Dosage:
Carnitor is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 200MG/ML | INJECTABLE | Prescription | INJECTION |